PRP Concepts
Developer of an autologous, point-of-care platelet-rich fibrin membrane (PRFM) system for regenerative wound care. The company documents clinical and preclinical evidence on sustained growth factor release from solid PRFM formulations and pursues regulatory clearance, manufacturing scale-up, and reimbursement pathways for chronic wound indications.
Industries
Nr. of Employees
small (1-50)
PRP Concepts
Products
Autologous platelet system for point-of-care PRFM preparation
A disposable, single-use kit and workflow enabling preparation of a solid platelet-rich fibrin membrane at point of care from a patient’s own blood for application to chronic wounds.
THE CASCADE® AUTOLOGOUS PLATELET SYSTEM
The CASCADE Autologous Platelet System is a single-use, disposable kit designed for point-of-care preparation of Platelet Rich Fibrin Membrane (PRFM) utilizing proprietary technology to deliver intact, live platelets in a solid membrane.
Autologous platelet system for point-of-care PRFM preparation
A disposable, single-use kit and workflow enabling preparation of a solid platelet-rich fibrin membrane at point of care from a patient’s own blood for application to chronic wounds.
THE CASCADE® AUTOLOGOUS PLATELET SYSTEM
The CASCADE Autologous Platelet System is a single-use, disposable kit designed for point-of-care preparation of Platelet Rich Fibrin Membrane (PRFM) utilizing proprietary technology to deliver intact, live platelets in a solid membrane.
Services
Hands-on training, demonstrations, and implementation support for clinicians to integrate PRFM preparation and application into standard wound care workflows.
Provision of peer-reviewed publications, clinical data, and resources to clinicians and investigators supporting trial participation and evidence review.
Continuing medical education and KOL engagement programs targeted at podiatrists and wound care specialists to accelerate adoption and appropriate clinical use.
Hands-on training, demonstrations, and implementation support for clinicians to integrate PRFM preparation and application into standard wound care workflows.
Provision of peer-reviewed publications, clinical data, and resources to clinicians and investigators supporting trial participation and evidence review.
Continuing medical education and KOL engagement programs targeted at podiatrists and wound care specialists to accelerate adoption and appropriate clinical use.
Expertise Areas
- Chronic wound care and regenerative biologics
- Autologous PRP/PRFM therapy
- Clinical trial design and biostatistics
- GMP manufacturing and quality assurance
Key Technologies
- Platelet-rich plasma preparation
- Platelet-rich fibrin membrane (PRFM) formation
- Centrifugation-based blood fractionation
- Growth factor release assays
News & Updates
Company states the autologous platelet system is an FDA 510(k)-cleared medical device for preparation of a platelet-rich fibrin membrane.
Company reports validated manufacturing and production-ready status to support commercial distribution.
Company references multiple peer-reviewed studies and a systematic review demonstrating PRP/PRFM activity in chronic wound healing (resources list includes >40 publications).
Company states the autologous platelet system is an FDA 510(k)-cleared medical device for preparation of a platelet-rich fibrin membrane.
Company reports validated manufacturing and production-ready status to support commercial distribution.
Company references multiple peer-reviewed studies and a systematic review demonstrating PRP/PRFM activity in chronic wound healing (resources list includes >40 publications).